Clinical significance and outcome of Aeromonas spp. infections among 204 adult patients
- PMID: 28258303
- PMCID: PMC7102105
- DOI: 10.1007/s10096-017-2945-4
Clinical significance and outcome of Aeromonas spp. infections among 204 adult patients
Abstract
The objectives of this investigation were to analyze the clinical patterns, risk groups, prognostic factors, and mortality of infections caused by Aeromonas spp. This was a retrospective study of adult patients with Aeromonas spp. isolates attended at the Hospital del Mar in Barcelona, Spain, between January 2006 and December 2012. Epidemiological data, antimicrobial susceptibility, clinical patterns, underlying illnesses, type of infection, admission to the intensive care unit (ICU), number of episodes, coinfection, antimicrobial therapy, and evolution were analyzed. A total of 221 clinical samples from 204 patients were positive for Aeromonas spp. The mean age of the patients was 67.6 years. The main clinical form of presentation was gastrointestinal (78.4%). Malignancy was the main risk group in 69 (33.8%) patients, and 48 (23.5%) were previously healthy. Twenty-one patients (10.3%) were admitted to the ICU. Infections were acquired in the hospital in 52.5% of the patients, and 28.9% were polymicrobial. The overall mortality (after 1 year of follow-up from the first positive culture) was 26.5%. Univariate analysis identified an association between increased mortality and the following variables: age ≥80 years, hospitalization, admission to the ICU, malignancy, extraintestinal infection, and appropriate antimicrobial therapy. In the multivariate analysis, age ≥80 years [odds ratio (OR), 4.37 [95% confidence interval (CI), 1.68-11.35; p = 0.002]], admission to the ICU (OR, 6.59 [95% CI, 2.17-19.99; p = 0.001]), and malignancy (OR, 3.62 [95% CI, 1.32-9.90; p = 0.012]) were significantly associated with mortality. Aeromonas infections are mainly gastrointestinal. The 1-year follow-up mortality rate was high. Old age (age ≥80 years), admission to the ICU, and malignancy were identified as independent risk factors for mortality.
Conflict of interest statement
None declared.
Figures
Similar articles
-
[Extraintestinal infection due to Aeromonas spp.: review of 38 cases].Enferm Infecc Microbiol Clin. 2007 Apr;25(4):235-41. doi: 10.1157/13100463. Enferm Infecc Microbiol Clin. 2007. PMID: 17386217 Review. Spanish.
-
Clinical Presentation, Antimicrobial Resistance, and Treatment Outcomes of Aeromonas Human Infections: A 14-Year Retrospective Study and Comparative Genomics of 2 Isolates From Fatal Cases.Clin Infect Dis. 2024 Nov 22;79(5):1144-1152. doi: 10.1093/cid/ciae272. Clin Infect Dis. 2024. PMID: 38759099 Free PMC article.
-
Nosocomial Gram-negative bacteremia in intensive care: epidemiology, antimicrobial susceptibilities, and outcomes.Int J Infect Dis. 2015 Aug;37:129-34. doi: 10.1016/j.ijid.2015.06.024. Epub 2015 Jul 6. Int J Infect Dis. 2015. PMID: 26159847
-
Comparison of skin and soft tissue infections caused by Vibrio and Aeromonas species.Surg Infect (Larchmt). 2014 Oct;15(5):576-80. doi: 10.1089/sur.2013.065. Epub 2014 Aug 15. Surg Infect (Larchmt). 2014. PMID: 25126885
-
Surgical site infection due to Aeromonas species: report of nine cases and literature review.Scand J Infect Dis. 2009;41(3):164-70. doi: 10.1080/00365540802660492. Scand J Infect Dis. 2009. PMID: 19117246 Review.
Cited by
-
Age-Dependent Variations in the Distribution of Aeromonas Species in Human Enteric Infections.Pathogens. 2025 Jan 28;14(2):120. doi: 10.3390/pathogens14020120. Pathogens. 2025. PMID: 40005497 Free PMC article.
-
Case Report: A rare infection of multidrug-resistant Aeromonas caviae in a pediatric case with acute lymphoblastic leukemia and review of the literature.Front Pediatr. 2024 May 13;12:1233600. doi: 10.3389/fped.2024.1233600. eCollection 2024. Front Pediatr. 2024. PMID: 38803640 Free PMC article.
-
Evaluation of the prevalence of Aeromonas spp., Campylobacter spp., and Clostridioides difficile in immunocompromised children with diarrhea.BMC Infect Dis. 2024 May 22;24(1):512. doi: 10.1186/s12879-024-09372-3. BMC Infect Dis. 2024. PMID: 38778271 Free PMC article.
-
Clinical Presentation and Outcomes Following Infection With Vibrio spp, Aeromonas spp, Chromobacterium violaceum, and Shewanella spp Water-Associated Organisms in Tropical Australia, 2015-2022.Open Forum Infect Dis. 2024 Jun 12;11(7):ofae319. doi: 10.1093/ofid/ofae319. eCollection 2024 Jul. Open Forum Infect Dis. 2024. PMID: 38975250 Free PMC article.
-
Practice of standardization of CLSI M45 A3 antimicrobial susceptibility testing of Infrequently Isolated or Fastidious Bacteria strains isolated from blood specimens in Guangdong Province 2017-2021.Front Microbiol. 2024 Apr 29;15:1335169. doi: 10.3389/fmicb.2024.1335169. eCollection 2024. Front Microbiol. 2024. PMID: 38741731 Free PMC article.
References
-
- Morris JG, Horneman A (2013) Aeromonas infections. UpToDate, Waltham, MA.. Available online at: http://www.uptodate.com/
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous